The German pharmaceutical company said buying the division, which makes Coppertone sun care products, Dr. Scholl’s foot health and allergy brand Claritin, was “a major milestone”.
Bayer said Merck would separately pay it $1 billion in a co-development deal over heart failure drugs.
It said the deal would help it develop sales outside the US.
Bayer also expects to become the second largest player in non-prescription, over-the-counter (OTC) products as a result of the acquisition.
“With this transaction, we are acquiring leading product brands,” said Bayer HealthCare boss Olivier Brandicourt.
Bayer said it expected the integration of the two businesses to generate significant cost savings of around $200 million per year by 2017.
Bayer also said increasing its commercial presence and rolling out Merck’s brands globally would amount to an additional $400 million in revenues per year by 2017.
EB7poOwvHS4At least 158 people have died in Spain's worst flooding disaster in generations. On October…
Google has been fined two undecillion (a two followed by 36 zeroes) roubles by a…
Embarking on a home remodel is an exciting journey, promising enhanced comfort, increased property value,…
The US presidential candidates continued to campaign across key swing states on October 20. Footage…
Elon Musk has said he will give away $1 million a day to a registered…
India and Canada have decided to expel their top envoys along with other diplomats as…